Treatment with Smyd3-ASOs suppressed liver tumor growth in a mouse model of chemical-induced hepatocellular carcinoma and inhibited the tumor growth rate, migration, and capacity by blocking cellular dedifferentiation and the expansion of hepatic cancer stem cells98. This evidence concerns the gene SMYD3 and neoplasm.